Glenmede Trust CO Na X Biotech Inc. Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding XBIT
# of Institutions
52Shares Held
4.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.67 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA945KShares$2.22 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny551KShares$1.3 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$583,4340.0% of portfolio
-
Geode Capital Management, LLC Boston, MA221KShares$518,5950.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $71.5M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...